Abstract:The aggregation of amyloid-β peptides (Aβ) is considered as one of the mainly possible causes of the Alzheimer's diseases (AD). How to suppress the formation of toxic Aβ aggregates has been intensively concerned over the past several decades. Increasing evidence shows that whether carbon nano-materials could suppress or promote the aggregation depend on their physicochemical properties. However, as amyloid fibrillization is a complex process, their interaction dynamics remains elusive. In this presentation, we have investigated the interaction between Aβ(16-22) peptides/full-length Aβ peptides and three kinds of carbon nanomaterials (carbon nanotube, fullerene, and graphene) by utilizing atomic force microscopy (AFM), electrostatic force microscopy (EFM), Thioflavin T (ThT) fluorescence, combined with molecular dynamic (MD) simulations. Our experimental results demonstrate that all of the three carbon nano-materials could suppress the process of Aβ fibrillation. EFM and ThT fluorescence results further confirmed that the Aβ peptides are strongly absorbed on the surface of carbon nano-materials by forming non-fibrillar aggregates. At the molecular scale, it is found that carbon nano-materials dramatically inhibit the formation of ordered β-sheet-rich structures as the strong hydrophobic and aromatic stacking interactions between carbon nano-materials and Aβ peptides. In comparison, the fullerenes exhibit the most excellent inhibitory ability by the strong aromatic stacking of the fullerene hexagonal rings with the Phe rings, as well as the outstanding biocompatibility. Furthermore, we found that the bare carbon nanotube could dissociate the preformed fibrils to some extent. Our results provide novel clues for studying interaction in amyloid/carbon-material system and seeking amyloidosis inhibitors with carbon nanomaterials, which may have important potentials in the development of drug candidates against Alzheimer's disease.

TiO2 nanoparticles promote β-amyloid fibrillation in vitro

TiO2 nanoparticles promote beta-amyloid fibrillation in vitro.

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Atomic-thick porous Pd nanosheets with antioxidant enzyme-like activities and photothermal properties for potential Alzheimer's disease treatment

Correction To: Gold Nanoparticles with Amyloid-Β Reduce Neurocell Cytotoxicity for the Treatment and Care of Alzheimer’s Disease Therapy

Studies of the Interaction Between Aβ Peptides and Carbon Nano-Materials

Impact of nanoplastics on Alzheimer 's disease: Enhanced amyloid-β peptide aggregation and augmented neurotoxicity

Self-assembly Hollow Manganese Prussian White Nanocapsules Attenuate Tau-related Neuropathology and Cognitive Decline.

Inhibition of Aβ Aggregation and Tau Phosphorylation with Functionalized Biomimetic Nanoparticles for Synergic Alzheimer's Disease Therapy

Nanomaterials for Modulating the Aggregation of β-Amyloid Peptides

Exploring The Mechanism Of Inhibition Of Au Nanoparticles On The Aggregation Of Amyloid-(16-22) Peptides At The Atom Level By All-Atom Molecular Dynamics

C3N Nanodots Inhibits Aβ Peptides Aggregation Pathogenic Path in Alzheimer's Disease.

Nanomaterials for Modulating the Aggregation of -Amyloid Peptides

Preparation of Nanomolecular Probe and Its Effect on the Degradation of Amyloid Β-Protein in Alzheimer’s Disease

Electrostatic assembly of gold nanoparticle and metal–organic framework nanoparticles attenuates amyloid β aggregate-mediated neurotoxicity

Size-effect of Gold Nanorods on Modulating the Kinetic Process of Amyloid-Β Aggregation

Titanium dioxide and carbon black nanoparticles disrupt neuronal homeostasis via excessive activation of cellular prion protein signaling

Effects of Carbon Nanoparticles on the Aggregation of Alzheimers Beta-Amyloid Peptide

Amyloid-β Peptide Aggregation and the Influence of Carbon Nanoparticles

Nanoparticle formulations in the diagnosis and therapy of Alzheimer's disease

Polydopamine/Ruthenium Nanoparticle Systems as Photothermal Therapy Reagents and Reactive Oxygen Species Scavengers for Alzheimer’s Disease Treatment